Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs VanEck Junior Gold Miners (GDXJ) Price & Performance

CVS Health CorpTrade
VanEck Junior Gold MinersTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs VanEck Junior Gold Miners — how do they compare? CVS Health Corp trades at $85.29 (market cap $112.29B), while VanEck Junior Gold Miners trades at $113.17 (market cap $8.22B). The key difference: CVS Health Corp is far larger — about 13.7× VanEck Junior Gold Miners's market cap, and CVS Health Corp pays a 3.03% dividend while VanEck Junior Gold Miners pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and VanEck Junior Gold Miners for 41 Days on average.

CVSGDXJ
Market Cap
$112.29B$8.22B
Volume
7,763,6763,212,198
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$110.60$156.19
52-Week Low
$70.08$87.56
Typical Hold Time
83 Days41 Days
Enterprise Value
$174.64B—
Dividend Yield
3.03%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.

The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.

VanEck Junior Gold Miners

GDXJ, the VanEck Junior Gold Miners ETF, is trading at $109.14, down 3.88% on the day, reflecting a bearish technical signal with selling pressure across moving averages and oscillators. Recent news highlights multiple junior gold mining companies being added to the ETF's index, potentially increasing its diversification and appeal. The ETF's current price is near key support levels, with the overall market sentiment influenced by gold price volatility and sector-specific developments.

The outlook for GDXJ is cautious due to bearish technical indicators and sector volatility, though inclusion of new companies may enhance long-term growth potential. Key risks include gold price fluctuations, mining operational risks, and broader market sentiment shifts. Investment opportunity lies in potential gold price appreciation and ETF rebalancing benefits, but requires careful risk management.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

GDXJ
100% Buy0% Sell
Avg holding period · 41 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About VanEck Junior Gold Miners

GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.

Read more on GDXJ →